1Shepherd J, Kastelein J J, Bittner VA, et al. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney dis- ease[J].Am J Cardiol,2008 ;51 (15) :1448-54.
3Yokta N, ODonnell M, Daniels F,et al. Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia reperfusion injury [J]. Am J Nephro1,2003 ;23 ( 1 ) : 13-7.
4Danesh FR, Sadeghi MM, Amro N, et al. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesang- ial cells via modulation of Rho GIpase/p21 sigraling pathway : implications for diabetic nephropathy[J].Proc Natl Acad Sci USA, 2002 ; 99 ( 12 ) : 8301-5.
5Oda H,Keane WF. Recent advance sinstatins and the kidney[J]. Kidney Int, 1999 ;71 ( Suppl ) :2 -5.
6Nogaki F, Muso E, Yashiro M, et al. Diomede [J]. Arterioscler Thromb Vaes Biol,2001 ;21 (8) : 1327-32.
二级参考文献10
1ATHYROSL V G, PAPAGEORGIOUL A A, Statins and renal funcition in patients with diabetes mellitus [J]. Curr Med Res Opin,2003, 19(7):615 - 617.
2RAVID M, BROSH D, RAVID- SAFRAN D, et al. Risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels,mean blood pressure, and hyperglycemia [J]. Arch Intern Med, 1998,158(9) :998 - 1004.
3JANDELETT - DAHM K, CAO Z, COX A T, et al. Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy [J].Kiney Int Suppl, 1999,56(s71): 831 - 36.
4MANN S J. Isolated systolic hypertension[J]. Medicographia, 1998,20(1):3.
5KAPLAN N M. The CARE Study: a postmarketing evaluation of ramipril in 11 100 patients. The Clinical Altace Real - World Efficacy(CARE) Investigators[J]. Clin Ther, 1996, 18(4) :658 - 670.
6ATHYROS V G, MIKHAILIDIS D P, PAPAGEORGION A A, et al,The effect of statins versus untreated dyslipidaemia on renal funcyion in patients with voronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study[J]. J Clin Pathol, 2004,57:728- 734.
7MOORE R. Therapeutic considerations for the use of stalin therapy in chronic renal disease[J]. Nephron Clin Pract,2003,95:107- 115.
8LI J J. Silent myocardial ischemia may be related to inflammatory response[J]. Med Hypotheses,2004,62:252 - 256.
9LI J J. Rapid effects on lipid profile and C - reactive protein by simvastatin in patients with hypercholesterolemia[J]. Clin Cardiol,2003,26:472-476.
